Inhibition of vascular endothelial growth factor‐A downregulates angiogenesis in psoriasis: A pilot study

BACKGROUND: Vascular Endothelial Growth Factor (VEGF)‐A‐mediated angiogenesis participates in the pathogenesis of psoriasis, thus inviting the hypothesis that anti‐VEGF‐A therapy could be beneficial in psoriasis. While anti‐angiogenic agents are used in oncology and ophthalmology, these therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Luengas‐Martinez, Andrea, Ismail, Dina, Paus, Ralf, Young, Helen S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10549813/
https://www.ncbi.nlm.nih.gov/pubmed/37799359
http://dx.doi.org/10.1002/ski2.245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10549813/
https://www.ncbi.nlm.nih.gov/pubmed/37799359
http://dx.doi.org/10.1002/ski2.245

Ejemplares similares